Ernst & Young

illustration of young entrepreneur pitching idea to raise venture capital fund
Biotech

Taxes, tariffs, interest rates hold key to biotech's future: EY

“This is probably one of the toughest years to predict,” Arda Ural, Ph.D., EY Americas Life Sciences Sector Leader, said on last week.
Kevin Dunleavy Jun 18, 2025 9:50am
bank vault cash open door money cash windfall

Pharma has $1T in firepower to spend on biotech innovation: EY

Jun 3, 2024 8:00am
money trend loss dollar stock down

Medtech M&A, IPOs, VC funding plummeted in 2022: EY

Oct 9, 2023 8:00am
concept of chess board with letters MA

Expect a 'buoyant year' in biopharma M&A with $1.7T to deploy

Feb 15, 2022 8:00am